Chung‐Han Lee
Impact in
- Cancer Research top 1%
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Renal cell carcinoma treatment 56
-
- Cancer Genomics and Diagnostics 15
- Co-authors
- Robert John Motzer (44 shared papers)James J.-D. Hsieh (14 shared papers)Kun‐Liang Guan (2 shared papers)Ken Inoki (2 shared papers)Ying‐Bei Chen (19 shared papers)A. Ari Hakimi (20 shared papers)Martin Henner Voss (31 shared papers)Boris Pasche (1 shared paper)
- Journals
- Clinical Cancer Research (5 papers)European Urology Oncology (5 papers)Clinical Genitourinary Cancer (5 papers)European Urology (5 papers)Journal for ImmunoTherapy of Cancer (4 papers)
- Partner nations
- United StatesSouth KoreaTaiwan
In The Last Decade
Chung‐Han Lee
122 papers receiving 8.0k citations
Chung‐Han Lee's Hit Papers
Peers
Comparison fields: 5 of 143
- Cancer Research 1.8k
- Oncology 2.9k
- Pulmonary and Respiratory Medicine 2.6k
- Immunology 939
- Molecular Biology 3.0k
Countries citing papers authored by Chung‐Han Lee
This map shows the geographic impact of Chung‐Han Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chung‐Han Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chung‐Han Lee more than expected).
Fields of papers citing papers by Chung‐Han Lee
This network shows the impact of papers produced by Chung‐Han Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chung‐Han Lee. The network helps show where Chung‐Han Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Chung‐Han Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 124 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumor mutational load predicts survival after immunotherapy across multiple cancer types Hit paper breakdown → | 2019 | 3019 |
| 2 | An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma Hit paper breakdown → | 2016 | 607 |
| 3 | TGF- : Duality of Function Between Tumor Prevention and Carcinogenesis Hit paper breakdown → | 2014 | 460 |
| 4 | Phase IB/II Trial of Lenvatinib Plus Pembrolizumab in Patients With Advanced Renal Cell Carcinoma, Endometrial Cancer, and Other Selected Advanced Solid Tumors Hit paper breakdown → | 2020 | 346 |
| 5 | 2006 | 162 | |
| 6 | 2018 | 142 | |
| 7 | 2018 | 142 | |
| 8 | Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non–Clear-Cell Renal Cell Carcinoma and Genomic Correlates Hit paper breakdown → | 2022 | 142 |
| 9 | 2021 | 141 | |
| 10 | 2007 | 134 | |
| 11 | Pembrolizumab plus lenvatinib as first-line therapy for advanced non-clear-cell renal cell carcinoma (KEYNOTE-B61): a single-arm, multicentre, phase 2 trial Hit paper breakdown → | 2023 | 113 |
| 12 | 2011 | 107 | |
| 13 | 1994 | 106 | |
| 14 | 2016 | 92 | |
| 15 | 2012 | 88 | |
| 16 | 2022 | 88 | |
| 17 | 2022 | 83 | |
| 18 | 2016 | 80 | |
| 19 | 2016 | 77 | |
| 20 | 1995 | 73 |
About Chung‐Han Lee
Chung‐Han Lee is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Oncology, Molecular Biology and Pathology and Forensic Medicine, having authored 124 papers that have together received 8.1k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (56 papers), Cancer Immunotherapy and Biomarkers (17 papers), Cancer Genomics and Diagnostics (15 papers), Renal and related cancers (13 papers), Bladder and Urothelial Cancer Treatments (9 papers), Advanced biosensing and bioanalysis techniques (6 papers), Breast Lesions and Carcinomas (5 papers) and Pancreatic and Hepatic Oncology Research (5 papers). The work is most often cited by research in Cancer Research (1.8k citations), Oncology (2.9k citations), Pulmonary and Respiratory Medicine (2.6k citations), Immunology (939 citations) and Molecular Biology (3.0k citations). Chung‐Han Lee has collaborated with scholars based in United States, South Korea and Taiwan. Frequent co-authors include Robert John Motzer, James J.-D. Hsieh, Kun‐Liang Guan, Ken Inoki, Ying‐Bei Chen, A. Ari Hakimi, Martin Henner Voss, Boris Pasche, Daniel R. Principe and Bock‐Gie Jung. Their work appears in journals such as Clinical Cancer Research, European Urology Oncology, Clinical Genitourinary Cancer, European Urology and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.